Developed & Manufactured by Biomedica

High quality ELISAs
Developed and manufactured by Biomedica

Featured Products & Promotions

Latest News
  • Periostin - A Serum Biomarker for Osteogenesis Imperfecta Progression
    Periostin - A Serum Biomarker for Osteogenesis Imperfecta Progression
    22 April, 2026
    Periostin - A Serum Biomarker for Osteogenesis Imperfecta Progression Osteogenesis Imperfecta (OI), also known as brittle bone disease, is a genetic disorder characterized by fragile bones that break easily, often with little or no apparent cause. It is caused by mutations in the genes responsible for producing collagen, a vital protein for bone strength and [...]
  • Sclerostin - A Biomarker for Vascular Risk in Diabetes
    Sclerostin - A Biomarker for Vascular Risk in Diabetes
    15 April, 2026
    Type 2 Diabetes Mellitus (T2DM) and Cardiovascular (CV) diseases Patients with T2DM have an elevated risk of developing CV diseases due to multiple factors. Chronic hyperglycemia, or elevated blood sugar levels, can cause damage to blood vessels promoting the development of atherosclerosis (1). Insulin resistance, a hallmark of T2DM, contributes to abnormal lipid profiles, such [...]
  • Monitoring Inflammatory Bowel Disease with Serum Marker LRG
    Monitoring Inflammatory Bowel Disease with Serum Marker LRG
    7 April, 2026
    Monitoring inflammatory responses with serum marker LRG Inflammatory Bowel Diseases (IBD) are chronic conditions characterized by inflammation of the gastrointestinal tract. The main types are Crohn's disease and ulcerative colitis. Crohn's can affect any part of the digestive tract and involves all layers of the intestinal wall, while ulcerative colitis primarily affects the colon and [...]
More News
Events
  • Biomedica at Osteologie in Salzburg
    19 June, 2023
    Biomedica features FGF23 ELISA - intact and C-terminal - assays Meet us at the OSTEOLOGIE Conference taking place from 22-24 June 2023 in Salzburg, Austria! We will exhibit at booth # 36 introducing our novel biomarker ELISA assays to investigate bone and cancer induced bone diseases (e.g. Periostin, Semaphorin 4D, LRG, and others). Our focus [...]
  • Biomedica @ Osteologie 2020 in Salzburg
    17 February, 2020
    Meet us at the Osteologie 2020, hosted by the Deutsche Gesellschaft für Endokrinologie and the Österreichische Gesellschaft für Knochen- und Mineralstoffwechsel, taking place from 12-14 March 2020 in Salzburg, Austria! We will exhibit together with our partners Fianostics & TAmiRNA at booth #1. Moreover,  we will present out new VEGF-A ELISA at our poster "Novel VEGF-A ELISA [...]
  • Meet Biomedica at ASN Kidney Week
    7 November, 2019
    Meet us during ASN Kidney Week taking place from November 5-10 2019 in Washington, DC at booth no. 2005 Hosted by the American Society of Nephrology it’s the world’s premier nephrology meeting with more than 13,000 kidney specialists from across the globe. It provides participants with exciting and challenging opportunities to exchange knowledge, learn about [...]
More Events